Tag: analyst coverage

Indiva to provide extraction services to TerrAscend

Indiva and TerrAscend partner to manufacture and process high-quality cannabis oil for TerrAscend patients and consumers LONDON, Ontario – August 7, 2019: Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) and TerrAscend (CSE:TER) (OTCQX:TRSSF) are pleased to announce the signing of an agreement to partner on an extraction services program (the “Agreement“). Under the terms of the Agreement, Indiva will…

Marijuana stock Harvest Health & Recreation sees revenue surge 39%

Harvest Health & Recreation (OTC: HRVSF) reported second-quarter results on Aug. 15. The vertically integrated marijuana dispensary saw revenue rise 39% sequentially to $26.6 million. Harvest Health & Recreation opened three new retail locations in Florida during the second quarter, bringing its total store count to 16 at the end of the period. This number should grow substantially in the quarters…

Have these tumbling cannabis stocks hit bottom yet?

Shares of cannabis stocks large and small were beaten down after soft second-quarter results disappointed investors expecting soaring sales of recreational cannabis in Canada that haven’t materialized. As a result, some of the world’s largest cannabis companies have stock prices miles below their peaks.  Has the market already pulled these cannabis kings down as far as it can, or could they…

Marijuana stock The Green Organic Dutchman sees revenue rise 20%

The Green Organic Dutchman Holdings (OTC: TGODF) reported second-quarter results on Aug. 13. The Canada-based cannabis company’s revenue rose 20% sequentially to 2.9 million Canadian dollars. Most of its sales were generated by its European operations, as the company just recently launched its Grower’s Circle — a small test of its medical marijuana distribution capabilities in Canada. Additionally, The Green Organic…

Biome Grow wins right to sell cannabis in Manitoba

Biome Grow Inc. (“Biome” or the “Company”) (CSE:BIO) (6OTA.F) (OTCQB: BIOIF) is pleased to announce that it has been licensed for the retail sale of cannabis in the province of Manitoba. This announcement comes on the back of recent approvals allowing Biome to distribute cannabis products in Saskatchewan and New Brunswick. With this announcement, Biome is licensed to distribute cannabis in five…

Stake your claim in Canadian cannabis with Hexo stock

There’s no way to possibly buy every pot stock on the market; there are just too many of them to choose from. Therefore, you’ll need to narrow your focus, and Canada is truly the epicenter of activity when it comes to legalized cannabis. While everyone else is focusing on well-known brands like Canopy Growth (NYSE: CGC ) and Aurora Cannabis  (NYSE: ACB ), I believe that Hexo  (NYSE: HEXO ) stock is…

Why Tilray stock is tanking today

What happened Shares of Tilray (NASDAQ: TLRY) are tanking today, down by 10.3% as of 10:40 a.m. EDT. The big drop reflects investors’ disappointment with the Canadian cannabis producer’s second-quarter results , which were announced on Tuesday after the market closed. So what Analysts expected Tilray to post a net loss of $0.25 per share. However, the company actually reported an adjusted net loss…

Cannabis Canada Daily: Supreme CEO says pot investing has hit inflection point

Pot investing ‘not just about hype anymore’: Supreme CEO The chief executive officer of Supreme Cannabis says that CannTrust Holdings’ ongoing regulatory scandal is shifting how investors view pot companies. “It’s going to separate good operators from the rest of the pack, because now you’re getting a lot of attention,” Supreme CEO Navdeep Dhaliwal told BNN Bloomberg Tuesday. “People are really…

Canadian pot company Tilray’s stock slips after posting a wider-than-expected loss for the second quarter

Tilray’s stock fell after the Canadian cannabis company reported a wider-than-expected loss for the second quarter after the markets closed Tuesday. Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv: Adjusted earnings per share: A loss of 32 cents vs. a loss of 25 cents expected Revenue: $45.9 million…